Skip to main content
P

Praesens

This company designs, builds, and scales rapidly deployable medical mobile laboratories for epidemic control and CBRN preparedness. They provide an integrated healthcare service delivery platform utilizing fit-for-purpose vehicles to ensure timely, accurate diagnostics close to the patient. The service ecosystem enhances health security capabilities by offering surge capacity and improving diagnostic access in underserved areas.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Access to reliable, timely diagnostic testing remains limited in many low‑resource regions, especially during epidemics, pandemics, and chemical‑biological‑radiological‑nuclear (CBRN) events. Inadequate laboratory infrastructure, insufficient trained personnel, and weak quality‑assurance systems create a “diagnostic last‑mile” gap that hampers early case detection and effective response.

Solution

Praesens Care delivers fully integrated, mobile medical laboratories that can be rapidly deployed to any terrain for epidemic control and CBRN preparedness. Each laboratory is built on a modular vehicle platform equipped with autonomous power supplies, biosafety isolation units, and on‑board molecular diagnostic instruments capable of detecting hundreds of pathogens. The system provides end‑to‑end sample processing—from collection and inactivation to real‑time PCR analysis—and transmits results securely to cloud‑based analytics dashboards for immediate clinical or public‑health decision‑making. By co‑locating testing capacity with patients, Praesens reduces turnaround time, expands patient coverage, and enhances biosafety while offering surge capacity for outbreak surges. The offering also includes training, workforce development, and ongoing technical support to ensure sustainable operation within local health systems.

Target Audience

Primary customers are national public‑health ministries, humanitarian NGOs, and military or civil‑defense agencies that require on‑site diagnostic capability for outbreak response, disease surveillance, and CBRN incident management in low‑resource or remote settings.

Features

  • Modular 6 × 6 m vehicle chassis configurable for laboratory, isolation, or command‑center modules.
  • Integrated power solution with diesel generator and battery storage delivering full energy autonomy for off‑grid operation.
  • On‑board biosafety isolator and containment cabinet enabling safe sample inactivation and handling of high‑risk pathogens.
  • Real‑time qRT‑PCR platform supporting multiplex assays for up to 200 infectious diseases and CBRN agents.
  • Secure data link and cloud analytics pipeline providing encrypted result transmission, automated reporting, and dashboard visualization.
  • Customizable assay menu aligned with national essential diagnostics lists and adaptable to emerging threats.
  • Comprehensive training program and remote technical support for local staff, including capacity‑building and quality‑assurance protocols.
  • Fleet‑management software for remote monitoring, maintenance scheduling, and performance analytics.
This profile is AI-generated and may contain inaccuracies.